These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 316377)

  • 1. Clinical and pharmacological evaluation of different preparations of oral erythromycin.
    Butzler JP; Vanhoof R; Clumeck N; de Mol P; Vanderlinden MP; Yourassowsky E
    Chemotherapy; 1979; 25(6):367-72. PubMed ID: 316377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of erythromycin ethyl succinate, stearate and estolate treatments of group A streptococcal infections of the upper respiratory tract.
    Janicki RS; Garnham JC; Worland MC; Grundy WE; Thomas JR
    Clin Pediatr (Phila); 1975 Dec; 14(12):1098-107. PubMed ID: 1104241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of erythromycin in respiratory tract infections.
    Walstad RA; Hellum KB
    Acta Otolaryngol Suppl; 1984; 407():50-4. PubMed ID: 6333775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin in respiratory tract infection.
    Gould JC
    Scott Med J; 1977 Dec; 22(5):355-9. PubMed ID: 414355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two oral forms of erythromycin in the treatment of acute respiratory tract infections. A multicentre general practice study.
    Macklin J; Barden R; Coles S
    J Int Med Res; 1989; 17(3):287-94. PubMed ID: 2670633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
    Shanson DC; Tidbury P; McNabb WR; Tadayon M
    J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.
    Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1412-7. PubMed ID: 1324644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on erythromycin stearate capsules (OE-7) (author's transl)].
    Yamashita T; Nishiyama M; Tsubura E
    Jpn J Antibiot; 1976 May; 29(5):552-8. PubMed ID: 933342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory and clinical studies on clarithromycin in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Feb; 42(2):264-79. PubMed ID: 2526242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
    Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L; Josefsson K
    Pharmacology; 1984; 29(6):305-11. PubMed ID: 6334320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
    Anderson G
    J Hosp Infect; 1991 Sep; 19 Suppl A():21-7. PubMed ID: 1684979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum erythromycin concentration following administration of 100 mg erythromycin ethyl succinate intramuscularly and 500 mg erythromycin stearate orally.
    McGimpsey JG; Webb CH; McCrea PH
    Int J Oral Surg; 1981; 10(Suppl 1):198-202. PubMed ID: 6807878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromycin stearate in acute maxillary sinusitis.
    Kalm O; Kamme C; Bergström B; Löfkvist T; Norman O
    Scand J Infect Dis; 1975; 7(3):209-17. PubMed ID: 241119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and sputum erythromycin concentrations in chronic bronchitis.
    Marlin GE; Davis PR; Rutland J; Berend N
    Thorax; 1980 Jun; 35(6):441-5. PubMed ID: 7434299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability.
    Saloranta P; Roos L; Elonen E; Allonen H
    J Antimicrob Chemother; 1989 Sep; 24(3):455-62. PubMed ID: 2808197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin levels in serum during treatment with erythromycin stearate and base.
    Saarni H; Kanto J; Allonen H
    Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute bacterial infections of the upper respiratory tract.
    Nadkarni MS; Shah PA; Thakurdesai S
    Curr Med Res Opin; 1977; 4(8):544-54. PubMed ID: 326492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of roxithromycin in comparison with erythromycin stearate in patients with lower respiratory tract infections.
    Paulsen O; Christensson BA; Hebelka M; Ljungberg B; Nilsson-Ehle I; Nyman L; Svensson R; Tüll P; Varga Z
    Scand J Infect Dis; 1992; 24(2):219-25. PubMed ID: 1641600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.